has anyone died from semaglutide The FDA issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and GLP-1 weight-loss drugs may also

5.2 Patient heterogeneity Surgical patients vary widely in age, comorbidities (diabetes, heart failure), and baseline immune status

Whether retatrutide, with its additional glucagon receptor agonism and potentially greater central nervous system penetration, shares or amplifies these neuroprotective effects is an open and genuinely important scientific question

NICE recommends gastroprotection for people at higher risk of stomach complications, and active GI symptoms from Wegovy could be an additional risk factor

Consult with Professionals: Before starting any new treatment, it is wise to consult with healthcare professionals to understand how GLP-1 medications might fit into your overall health plan

Adjust medication dosage: Based on blood glucose monitoring results, adjust medication dosage in a timely manner under the guidance of a doctor to avoid the occurrence of hypoglycemia

Those side effects are very real, Turner says